PDB26 Evidence Requirements in Australia for Drug Reimbursement: The Survival of Cost Minimisation Analysis

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.357
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost Minimisation Analysis of Provision of Oxygen at Home: Are the Drug Tariff Guidelines Cost Effective?

BMJ
1999English

Costs and Cost-Minimisation Analysis.

BMJ
1993English

Lessons for Adaptive Licensing: Analysis of Conditionally Approved EMA Compounds, Their Reimbursement Status and Regulatory/Reimbursement Data Requirements

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Centers for Medicare & Medicaid Services’ Decision on Drug-Coated Balloons: No Additional Reimbursement Despite Higher Cost and Highest Levels of Scientific Evidence

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2018English

Cost Minimisation of Product Transhipment for Physical Distribution Management

Journal of Transport and Supply Chain Management
ManagementTransportationManufacturing EngineeringManagement ScienceIndustrialManagement Information SystemsInformation SystemsOperations Research
2013English

Divergent Evidence Requirements Comparing the Authorization and Reimbursement Processes of High-Risk Medical Devices – The European Situation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Economic Evaluation and Cost-Effectiveness Threshold in Practice of Decision-Making on Orphan Drug Reimbursement in Poland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Cost Analysis of Rapid Diagnostics for Drug-Resistant Tuberculosis

BMC Infectious Diseases
Infectious Diseases
2018English

The Barriers to Reimbursement Success for Non-Small Cell Lung Cancer Therapies in Australia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy